DCF — MARSHFIELD MEDICAL CENTER-EAU CLAIRE
Enterprise Value: $-189.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-189.8M
Enterprise Value
$-63.5M
PV of Cash Flows
$-126.3M
PV of Terminal Value
$-203.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $221.0M | $-9.9M | -5.0% | $-19.3M | $-17.5M |
| Year 2 | $227.6M | $-8.0M | -4.0% | $-17.6M | $-14.5M |
| Year 3 | $234.5M | $-5.9M | -3.0% | $-15.8M | $-11.9M |
| Year 4 | $241.5M | $-4.8M | -2.0% | $-15.1M | $-10.3M |
| Year 5 | $248.8M | $-4.4M | -2.0% | $-14.9M | $-9.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-189.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$214.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000186410618
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5